About CRS Sites
CRS Sites is a Healthcare company based in Franklin (United States) founded in 2008, and was acquired by Brixey & Meyer Capital in November 2015. Site management organization offering its services in Ohio and Tennessee. CRS Sites offers products and services including Clinical Trial Network. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and Inclinix; 3 of its 3 listed competitors have raised funding.
Company details
Clinical Research Solutions (CRS) was founded in 2008 and is headquartered in Franklin, United States. Operations are focused on site management for multi-therapeutic independent research facilities. Phase I-IV clinical trials are conducted for pharmaceutical, nutritional, and medical device sectors. Services include study start-up, clinical staff provision, and protocol enrollment. Trials address conditions such as Alzheimers Disease, Type 2 Diabetes, and Prostate Cancer, with activities spanning Ohio and Tennessee.
- Headquarters Franklin, United States
- Stage Acquired
- SectorsHealthcare
- Website crssites.com
- Social X Facebook
- Acquired by Brixey & Meyer Capital (Nov 2015)
- Investors
- Acquired byBrixey & Meyer Capital
(Nov 2015)
Products & Services of CRS Sites
CRS Sites offers a comprehensive portfolio of products and services, including Clinical Trial Network.
Provides platform for efficient clinical trial management and enrollment.
Investors in CRS Sites
CRS Sites has secured backing from 1 investor. Prominent investors backing the company include Brixey & Meyer Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private investment firm focused on lower middle market. | bmcgrowth.com | Cincinnati, United States |
Investor details for CRS Sites
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CRS Sites
2 dated milestones of CRS Sites across 7 years, from founding to its latest funding, stage changes and deals.
- Founded CRS Sites is founded.
- Exit Acquired by Brixey & Meyer Capital.
Competitors of CRS Sites
CRS Sites has 3 listed competitors in our database, 3 of them funded. They include Elligo, Acurian and Inclinix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elligohealthresearch.com | 2016 | Austin, United States | $176.48M | 280 | Patient recruitment and site activation services are provided by Elligo. | |
| acurian.com | 1998 | Horsham, United States | $27M | Patient enrollment and retention solutions for clinical trials are offered. | ||
| inclinix.com | 1999 | Wilmington, United States | $10.5M | Customized solutions for clinical trial enrollment are provided. |
Detailed competitors of CRS Sites
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as CRS Sites (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Crs Sites
Complete news archive for CRS Sites
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CRS Sites
CRS Sites was founded in 2008.
CRS Sites is headquartered in Franklin, United States.
Clinical Research Solutions (CRS) was founded in 2008 and is headquartered in Franklin, United States. Operations are focused on site management for multi-therapeutic independent research facilities. Phase I-IV clinical trials are conducted for pharmaceutical, nutritional, and medical device sectors. Services include study start-up, clinical staff provision, and protocol enrollment. Trials address conditions such as Alzheimers Disease, Type 2 Diabetes, and Prostate Cancer, with activities spanning Ohio and Tennessee.
CRS Sites offers Clinical Trial Network.
CRS Sites has 1 investor. Key investors include Brixey & Meyer Capital.
Yes. CRS Sites was acquired by Brixey & Meyer Capital in November 2015.